Closed

NHS National Framework for Trastuzumab 600mg Subcutaneous Injection

NHS England

Value
£102,960,000
Published
5 Aug 2026
Deadline
19 Aug 2026
Procedure
Not stated
Category
33600000 — Pharmaceutical products
Location
UKC, United Kingdom
Notice reference
074125-2026

Requirements summary

NHS England is planning a national framework agreement for supply of Trastuzumab 600mg subcutaneous injection, a pharmaceutical product, under offer reference CM/TNS/26/5762. The framework period runs from 1 June 2027 to 31 August 2028, with options to extend up to 24 months in total, and the estimated value is GBP 102,960,000 gross (GBP 85,800,000 net). The notice is a preliminary market engagement stage, inviting current and potential suppliers planning to launch relevant molecules to register interest.

Key requirements

  • Framework supply of Trastuzumab 600mg subcutaneous injection (Lot 1)
  • Framework period 1 June 2027 to 31 August 2028, with extension options up to 24 months total
  • Delivery across listed English regions (UKC, UKD, UKF, UKG, UKH, UKJ, UKK)
  • Estimated value GBP 102.96m gross (GBP 85.8m net)
  • Suppliers may need to confirm product launch timing within the framework period
  • Tender structure and KPIs to be discussed at preliminary market engagement; SME suitability indicated

Similar open notices

NHS National Framework for Trastuzumab 600mg Subcutaneo… | ProposAI